Transcription of HIGHLIGHTS OF PRESCRIBING INFORMATION QSYMIA …
{{id}} {{{paragraph}}}
HIGHLIGHTS OF PRESCRIBING INFORMATION These HIGHLIGHTS do not include all the INFORMATION needed to use QSYMIA safely and effectively. See full PRESCRIBING INFORMATION for QSYMIA . QSYMIA (phentermine and topiramate extended-release) capsules, for oral use, CIV Initial Approval: 2012 ----------------------------RECENT MAJOR CHANGES-------------------------- Warnings and Precautions ( )..10/2020 --------------------INDICATIONS AND USAGE------------------------- QSYMIA is a combination of phentermine, a sympathomimetic amine anorectic, and topiramate extended-release, an antiepileptic drug, indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m2 or greater (obese) (1) or 27 kg/m2 or greater (overweight) in the presence of at least oneweight-related como
5.15 Kidney Stones 5.16 Oligohidrosis and Hyperthermia ... Determine the patient’s BMI. BMI is calculated by dividing weight (in kilograms) by height (in meters) ... based on height [inches (in) or centimeters (cm)] and weight [pounds (lb) or kilograms (kg)] is provided below. Table 1. BMI Conversion Chart . Weight (lb) 125 . 130 . 135 . 140 ...
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}